TMCO7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.494810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.655700E-02
Normal-vs-Stage2
1.569220E-01
Normal-vs-Stage3
1.085990E-01
Normal-vs-Stage4
9.577800E-01
Stage1-vs-Stage2
5.044400E-01
Stage1-vs-Stage3
5.776200E-01
Stage1-vs-Stage4
7.302200E-02
Stage2-vs-Stage3
3.214800E-01
Stage2-vs-Stage4
1.251040E-01
Stage3-vs-Stage4
1.044360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.389240E-01
Normal-vs-AfricanAmerican
6.537200E-01
Normal-vs-Asian
1.839940E-02
Caucasian-vs-AfricanAmerican
1.806010E-01
Caucasian-vs-Asian
2.911900E-02
AfricanAmerican-vs-Asian
1.028480E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.654770E-01
Normal-vs-Female
1.457370E-01
Male-vs-Female
6.934400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.349400E-01
Normal-vs-Age(41-60Yrs)
1.847240E-01
Normal-vs-Age(61-80Yrs)
1.410590E-01
Normal-vs-Age(81-100Yrs)
3.303400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.592800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.008200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.751600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.784390E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.757400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.363200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.363700E-02
Normal-vs-Daily Drinker
9.179900E-02
Normal-vs-Weekly Drinker
1.988150E-01
Normal-vs-Occasional Drinker
3.325200E-01
Normal-vs-Social Drinker
3.680400E-01
Non Drinker-vs-Daily Drinker
9.296600E-01
Non Drinker-vs-Weekly Drinker
5.183800E-01
Non Drinker-vs-Occasional Drinker
1.723360E-01
Non Drinker-vs-Social Drinker
2.045600E-01
Daily Drinker-vs-Weekly Drinker
5.216200E-01
Daily Drinker-vs-Occasional Drinker
2.013400E-01
Daily Drinker-vs-Social Drinker
2.351000E-01
Weekly Drinker-vs-Occasional Drinker
5.865000E-01
Weekly Drinker-vs-Social Drinker
6.113800E-01
Occasional Drinker-vs-Social Drinker
9.970600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.628400E-01
Normal-vs-Grade 2
9.505600E-01
Normal-vs-Grade 3
9.232000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.419210E-01
Grade 1-vs-Grade 3
1.078030E-01
Grade 1-vs-Grade 4
9.628400E-01
Grade 2-vs-Grade 3
5.765400E-01
Grade 2-vs-Grade 4
9.505600E-01
Grade 3-vs-Grade 4
9.232000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.725030E-01
Normal-vs-NonDiabetic
9.798500E-02
Diabetic-vs-NonDiabetic
8.093400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.634200E-02
Normal-vs-NoPancreatitis
1.425640E-01
Pancreatitis-vs-NoPancreatitis
5.023800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.471970E-01
Normal-vs-N1
1.754990E-01
N0-vs-N1
4.971000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.804000E-01
Normal-vs-TP53-NonMutant
3.118600E-01
TP53-Mutant-vs-TP53-NonMutant
9.116800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
